Related Experiment Videos
In vitro effects of recombinant human interferon gamma on human mesothelioma cell lines
1Laboratorie de Pathologie Cellulaire et Moléculaire de l'Environnement, INSERM U139, C.H.U. Henri Mondor, Créteil, France.
Abstract:
Malignant mesothelioma is a tumor arising from serous surfaces and often related to asbestos exposure. Malignant mesothelioma is resistant to various forms of therapy. Radiotherapy, surgery or chemotherapy only slightly improve prognosis. IFN-gamma produces complete or partial responses in stage-I patients with malignant mesothelioma. The in vitro biological effect of IFN-gamma on malignant mesothelioma cells remains poorly elucidated. In the present study, 32 well-characterized human mesothelioma cell lines (HMCL) were treated with r-hu IFN-gamma at 4 doses and cell growth was determined by a colorimetric method (MTT assay). Among the 32 HMCLs tested, II exhibited significant cell-growth inhibition; 16 were insensitive to r-hu IFN-gamma, and 5 were slightly inhibited. The sensitive cell lines were strongly inhibited by r-hu IFN-gamma. Our results show that HMCL exhibit a large range of responses to r-hu IFN-gamma, some of which can be compared with those obtained in vivo in humans.
Insights
Interferon-gamma (IFN-gamma) shows varied effects on malignant mesothelioma cells. Some cell lines demonstrated significant growth inhibition, suggesting potential therapeutic applications for this asbestos-related cancer.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Malignant mesothelioma is a rare and aggressive cancer linked to asbestos exposure.
- Current therapies offer limited improvement in prognosis for mesothelioma patients.
- Interferon-gamma (IFN-gamma) has shown promise in treating early-stage mesothelioma.
Purpose of the Study:
- To investigate the in vitro biological effects of recombinant human Interferon-gamma (r-hu IFN-gamma) on human mesothelioma cell lines (HMCL).
- To determine the range of responses of different HMCLs to r-hu IFN-gamma treatment.
Main Methods:
- Thirty-two well-characterized human mesothelioma cell lines (HMCL) were treated with r-hu IFN-gamma at four different doses.
- Cell growth inhibition was assessed using a colorimetric MTT assay.
Main Results:
- A significant range of cellular responses to r-hu IFN-gamma was observed among the 32 HMCLs.
- Eleven HMCLs exhibited significant growth inhibition by r-hu IFN-gamma.
- Sixteen HMCLs were insensitive, and five showed slight inhibition.
Conclusions:
- Human mesothelioma cell lines display heterogeneous sensitivity to r-hu IFN-gamma.
- The observed in vitro responses correlate with in vivo patient outcomes, indicating potential for IFN-gamma therapy.